The ability to generate functional beta cells from pluripotent and adult stem cells will provide access to unlimited numbers of these cells for transplantation for the treatment of type 1 diabetes, for studying their role in disease states and for screens aimed at defining the mechanisms by which key regulators control their proliferation and maturation. This proposal outlines an integrative series of studies by seven different research groups that combine tissue engineering and cell-processing strategies with stem cell and endothelial cell biology to generate functional islet like structures with differentiated cells generated from human embryonic stem cells, human induced pluripotent stem cells (collectively referred to as pluripotent stem cells) and adult pancreatic stem cells.
The first aim focuses on defining the signaling pathways and cellular interactions that regulate development and maturation of insulin producing cells from pluripotent stem cells.
The second aim will use similar approaches to study the regulatory pathways and cell populations that control the proliferation and differentiation of a recently identified stem cell in the adult human pancreas. The experiments outlined in the third aim focus on generating endothelial progenitor populations from different sources and investigating the capacity of these populations to promote beta cell differentiation, survival and maturation. The goal of the final aim is to test the function of the cell populations and engineered tissues generated in the project by transplantation into different mouse models of diabetes. The outcome of these studies will provide important new insights into the regulation of beta cell development and maturation from stem and progenitor populations in culture. This information will be instrumental in developing strategies for the routine and large-scale production of functional beta cells in culture and for promoting regeneration from stem cells within the pancreas. These advances will pave the way to develop novel beta cell replacement and/or beta cell regeneration therapies for the treatment of type 1 diabetes.
The goals are to study the processes that control the generation and maturation of insulin producing beta cells from pluripotent stem cells and adult pancreatic-derived stem cells. The new information generated from this work will provide the basis for establishing methods to produce unlimited numbers of beta cells for transplantation for the treatment of type 1 diabetes.
|Amer, Luke D; Holtzinger, Audrey; Keller, Gordon et al. (2015) Enzymatically degradable poly(ethylene glycol) hydrogels for the 3D culture and release of human embryonic stem cell derived pancreatic precursor cell aggregates. Acta Biomater 22:103-10|
|Nostro, M Cristina; Sarangi, Farida; Yang, Chaoxing et al. (2015) Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Reports 4:591-604|
|Holtzinger, Audrey; Streeter, Philip R; Sarangi, Farida et al. (2015) New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development 142:4253-65|
|Amer, Luke D; Mahoney, Melissa J; Bryant, Stephanie J (2014) Tissue engineering approaches to cell-based type 1 diabetes therapy. Tissue Eng Part B Rev 20:455-67|
|Jaroch, David B; Lu, Jing; Madangopal, Rajtarun et al. (2013) Mouse and human islets survive and function after coating by biosilicification. Am J Physiol Endocrinol Metab 305:E1230-40|
|Ungrin, Mark D; Clarke, Geoff; Yin, Ting et al. (2012) Rational bioprocess design for human pluripotent stem cell expansion and endoderm differentiation based on cellular dynamics. Biotechnol Bioeng 109:853-66|
|Woodford, Curtis; Zandstra, Peter W (2012) Tissue engineering 2.0: guiding self-organization during pluripotent stem cell differentiation. Curr Opin Biotechnol 23:810-9|
|Nostro, Maria Cristina; Keller, Gordon (2012) Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine. Semin Cell Dev Biol 23:701-10|